chartexchange

Dare Bioscience Inc (DARE) Q3 2026 Earnings Call Highlights: First Product Sales Begin as ...

GuruFocus | Nov 17, 2026 12:01 AM EST

Dare Bioscience Inc (DARE) reported $11.5 million in cash, initial Florisync LF5 revenue, and 182 providers already prescribing Dare to Play ahead of its November dispensing launch. Related Stocks: DARE ,

Read original article